EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis
FRA:EWL - Deutsche Boerse Ag - US28176E1082 - Common Stock - Currency: EUR
Overall EWL gets a fundamental rating of 7 out of 10. We evaluated EWL against 55 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making EWL a very profitable company, without any liquidiy or solvency issues. While showing a medium growth rate, EWL is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year EWL was profitable.
EWL had a positive operating cash flow in the past year.
In the past 5 years EWL has always been profitable.
Each year in the past 5 years EWL had a positive operating cash flow.
1.2 Ratios
The Return On Assets of EWL (32.06%) is better than 100.00% of its industry peers.
Looking at the Return On Equity, with a value of 43.57%, EWL belongs to the top of the industry, outperforming 98.04% of the companies in the same industry.
EWL's Return On Invested Capital of 12.27% is amongst the best of the industry. EWL outperforms 92.16% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EWL is significantly above the industry average of 8.18%.
The last Return On Invested Capital (12.27%) for EWL is well below the 3 year average (20.11%), which needs to be investigated, but indicates that EWL had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 32.06% | ||
| ROE | 43.57% | ||
| ROIC | 12.27% |
ROA(3y)17%
ROA(5y)15.7%
ROE(3y)24.35%
ROE(5y)23.26%
ROIC(3y)20.11%
ROIC(5y)19.51%
1.3 Margins
EWL's Profit Margin of 73.98% is amongst the best of the industry. EWL outperforms 100.00% of its industry peers.
EWL's Profit Margin has improved in the last couple of years.
EWL has a better Operating Margin (27.73%) than 100.00% of its industry peers.
EWL's Operating Margin has been stable in the last couple of years.
EWL's Gross Margin of 78.63% is amongst the best of the industry. EWL outperforms 82.35% of its industry peers.
EWL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.73% | ||
| PM (TTM) | 73.98% | ||
| GM | 78.63% |
OM growth 3Y-0.54%
OM growth 5Y0.18%
PM growth 3Y7.55%
PM growth 5Y3.78%
GM growth 3Y0.73%
GM growth 5Y0.6%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EWL is creating value.
The number of shares outstanding for EWL has been reduced compared to 1 year ago.
EWL has less shares outstanding than it did 5 years ago.
EWL has a better debt/assets ratio than last year.
2.2 Solvency
EWL has an Altman-Z score of 9.86. This indicates that EWL is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 9.86, EWL belongs to the top of the industry, outperforming 94.12% of the companies in the same industry.
The Debt to FCF ratio of EWL is 1.25, which is an excellent value as it means it would take EWL, only 1.25 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.25, EWL belongs to the top of the industry, outperforming 92.16% of the companies in the same industry.
A Debt/Equity ratio of 0.06 indicates that EWL is not too dependend on debt financing.
EWL has a better Debt to Equity ratio (0.06) than 92.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 1.25 | ||
| Altman-Z | 9.86 |
ROIC/WACC1.34
WACC9.15%
2.3 Liquidity
EWL has a Current Ratio of 3.46. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 3.46, EWL is doing good in the industry, outperforming 76.47% of the companies in the same industry.
EWL has a Quick Ratio of 2.89. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
EWL's Quick ratio of 2.89 is amongst the best of the industry. EWL outperforms 84.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.46 | ||
| Quick Ratio | 2.89 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 6.37% over the past year.
EWL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.89% yearly.
EWL shows a decrease in Revenue. In the last year, the revenue decreased by -3.40%.
Measured over the past years, EWL shows a quite strong growth in Revenue. The Revenue has been growing by 10.03% on average per year.
EPS 1Y (TTM)6.37%
EPS 3Y10.64%
EPS 5Y9.89%
EPS Q2Q%13.56%
Revenue 1Y (TTM)-3.4%
Revenue growth 3Y11.04%
Revenue growth 5Y10.03%
Sales Q2Q%-8.54%
3.2 Future
The Earnings Per Share is expected to grow by 7.98% on average over the next years.
The Revenue is expected to grow by 5.69% on average over the next years.
EPS Next Y3.46%
EPS Next 2Y0.07%
EPS Next 3Y4.38%
EPS Next 5Y7.98%
Revenue Next Year-3.3%
Revenue Next 2Y-1.15%
Revenue Next 3Y2.62%
Revenue Next 5Y5.69%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 26.12 indicates a quite expensive valuation of EWL.
Based on the Price/Earnings ratio, EWL is valued a bit cheaper than the industry average as 70.59% of the companies are valued more expensively.
EWL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.19, which is the current average of the S&P500 Index.
EWL is valuated quite expensively with a Price/Forward Earnings ratio of 27.78.
EWL's Price/Forward Earnings is on the same level as the industry average.
EWL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.37.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.12 | ||
| Fwd PE | 27.78 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EWL is on the same level as its industry peers.
EWL's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 86.37 | ||
| EV/EBITDA | 21.41 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
EWL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)7.54
PEG (5Y)2.64
EPS Next 2Y0.07%
EPS Next 3Y4.38%
5. Dividend
5.1 Amount
No dividends for EWL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EDWARDS LIFESCIENCES CORP
FRA:EWL (1/22/2025, 7:00:00 PM)
66.86
-0.24 (-0.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners86.67%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap39.43B
Analysts73.33
Price Target77.1 (15.32%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.26%
Min EPS beat(2)-2.08%
Max EPS beat(2)1.57%
EPS beat(4)1
Avg EPS beat(4)-0.84%
Min EPS beat(4)-2.52%
Max EPS beat(4)1.57%
EPS beat(8)2
Avg EPS beat(8)-0.87%
EPS beat(12)3
Avg EPS beat(12)-2.04%
EPS beat(16)5
Avg EPS beat(16)-0.79%
Revenue beat(2)0
Avg Revenue beat(2)-8.94%
Min Revenue beat(2)-13.79%
Max Revenue beat(2)-4.1%
Revenue beat(4)0
Avg Revenue beat(4)-4.84%
Min Revenue beat(4)-13.79%
Max Revenue beat(4)-0.38%
Revenue beat(8)1
Avg Revenue beat(8)-2.89%
Revenue beat(12)1
Avg Revenue beat(12)-3.12%
Revenue beat(16)3
Avg Revenue beat(16)-2.37%
PT rev (1m)6.19%
PT rev (3m)9.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-23.85%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-19.07%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-6.92%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.12 | ||
| Fwd PE | 27.78 | ||
| P/S | 7.33 | ||
| P/FCF | 86.37 | ||
| P/OCF | 51.07 | ||
| P/B | 4.31 | ||
| P/tB | 5.9 | ||
| EV/EBITDA | 21.41 |
EPS(TTM)2.56
EY3.83%
EPS(NY)2.41
Fwd EY3.6%
FCF(TTM)0.77
FCFY1.16%
OCF(TTM)1.31
OCFY1.96%
SpS9.13
BVpS15.5
TBVpS11.34
PEG (NY)7.54
PEG (5Y)2.64
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 32.06% | ||
| ROE | 43.57% | ||
| ROCE | 14.14% | ||
| ROIC | 12.27% | ||
| ROICexc | 20.57% | ||
| ROICexgc | 33.67% | ||
| OM | 27.73% | ||
| PM (TTM) | 73.98% | ||
| GM | 78.63% | ||
| FCFM | 8.48% |
ROA(3y)17%
ROA(5y)15.7%
ROE(3y)24.35%
ROE(5y)23.26%
ROIC(3y)20.11%
ROIC(5y)19.51%
ROICexc(3y)24.76%
ROICexc(5y)24.76%
ROICexgc(3y)32.94%
ROICexgc(5y)34.79%
ROCE(3y)23.16%
ROCE(5y)22.47%
ROICexcg growth 3Y-1.5%
ROICexcg growth 5Y-7.31%
ROICexc growth 3Y0.66%
ROICexc growth 5Y-2.73%
OM growth 3Y-0.54%
OM growth 5Y0.18%
PM growth 3Y7.55%
PM growth 5Y3.78%
GM growth 3Y0.73%
GM growth 5Y0.6%
F-Score7
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 1.25 | ||
| Debt/EBITDA | 0.35 | ||
| Cap/Depr | 220.76% | ||
| Cap/Sales | 5.86% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 47.21% | ||
| Profit Quality | 11.46% | ||
| Current Ratio | 3.46 | ||
| Quick Ratio | 2.89 | ||
| Altman-Z | 9.86 |
F-Score7
WACC9.15%
ROIC/WACC1.34
Cap/Depr(3y)206.04%
Cap/Depr(5y)261.97%
Cap/Sales(3y)5.22%
Cap/Sales(5y)6.27%
Profit Quality(3y)66.94%
Profit Quality(5y)73.09%
High Growth Momentum
Growth
EPS 1Y (TTM)6.37%
EPS 3Y10.64%
EPS 5Y9.89%
EPS Q2Q%13.56%
EPS Next Y3.46%
EPS Next 2Y0.07%
EPS Next 3Y4.38%
EPS Next 5Y7.98%
Revenue 1Y (TTM)-3.4%
Revenue growth 3Y11.04%
Revenue growth 5Y10.03%
Sales Q2Q%-8.54%
Revenue Next Year-3.3%
Revenue Next 2Y-1.15%
Revenue Next 3Y2.62%
Revenue Next 5Y5.69%
EBIT growth 1Y-12.15%
EBIT growth 3Y10.43%
EBIT growth 5Y10.23%
EBIT Next Year1.9%
EBIT Next 3Y5.07%
EBIT Next 5Y6.64%
FCF growth 1Y-54.13%
FCF growth 3Y-0.91%
FCF growth 5Y-1.68%
OCF growth 1Y-38.4%
OCF growth 3Y-5.29%
OCF growth 5Y-0.68%